MedPath

Examination of combination and maintenance therapy with Adapalene Gel 0.1% for acne vulgaris

Not Applicable
Conditions
Acne vulgaris
Registration Number
JPRN-UMIN000004442
Lead Sponsor
Tokyo Woman's Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
350
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients taking some medications (orally,topically, or injective agents, or chemical treatments) expected to be effective to acne vulgaris within one month before the registration of this research. 2) Patients with hypersensitivity to any of the study drugs 3) Patients continuously receiving non-steroidal anti-inflammatory drugs(ibuprofen,etc) 4) Women who are pregnant,might be pregnant or lactating or planning a pregnancy 5) Patients who are considered to be unsuitable for this study by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath